Skip to main content

Health care providers’ perspectives on providing end-of-life psychiatric care in cardiology and oncology hospitals: a cross-sectional questionnaire survey

Abstract

Background

Psychological distress is a major concern for patients with end-stage heart failure (HF). However, psychiatric care for patients with HF is not as organized as that for patients with cancer. Therefore, the aim of this study was to elucidate and compare the barriers faced by health care providers of cardiology and oncology hospitals in providing end-of-life psychiatric care to patients with HF and cancer, respectively.

Methods

We conducted a cross-sectional questionnaire survey among the health care providers of Japan. Questionnaires were mailed to physicians and nurses of 427 cardiology and 347 oncology hospitals in March 2018 to assess health care providers’ perspectives. First, we compared the scores of the Palliative Care Difficulties Scale and the original scale of end-of-life psychiatric care difficulties between health care providers of cardiology and oncology hospitals. Second, we asked the health care providers to describe the barriers to providing end-of-life psychiatric care with an open-ended question and then compared the freely-provided descriptions using content analysis.

Results

A total of 213 cardiology and 224 oncology health care providers responded to the questionnaire. No significant differences were found between health care providers of cardiology and oncology hospitals in the frequency of experiencing barriers to providing end-of-life psychiatric care (59.8% and 62.2%, respectively). A content analysis identified the following eight barriers: “patients’ personal problems,” “family members’ problems,” “professionals’ personal problems,” “communication problems between professionals and patients,” “problems specific to end-of-life care,” “problems specific to psychiatric care,” “problems of institution or system,” and “problems specific to non-cancer patients.” The “problems specific to noncancer patients” was described more frequently by health care providers in cardiology hospitals than that in oncology hospitals. However, there were no significant differences in other items between the two.

Conclusion

Although health care providers of both cardiology and oncology hospitals faced barriers to providing end-of-life psychiatric care, those of cardiology hospitals particularly faced challenges pertaining to non-cancer patients, such as unpredictability of prognosis or insufficiency of guideline development. A system of psychiatric care, specifically for patients with HF, should be established.

Peer Review reports

Background

Heart failure (HF) is potentially fatal, unless a heart transplantation is performed, and it is a serious healthcare and economic burden on patients and their caregivers. The World Health Organization estimated the worldwide mortality from cardiovascular disease at 15.2 million in 2016 [1], making it the most common cause of death (40%) among middle-aged and older adults [2]. Despite the recent rapid progress in medical treatments, the median survival rate after patients’ first hospitalization is low in severe HF (2.1 years) [3]. In addition, HF has inflicted a burden of $180 million on the global health system [4].

Patients with advanced HF commonly experience psychological symptoms, the most common of which are depression and anxiety, as well as physical symptoms, such as dyspnea, pain, or fatigue [5, 6]. Severe clinical depression is diagnosed in 12 to 33% of all patients with heart disease [7, 8] and in 38 to 42% of those with severe HF, featuring New York Heart Association class III-IV symptoms [9]. Among patients with HF, 29% exhibit severe and clinically significant anxiety symptoms, and 9% have anxiety disorders, including generalized anxiety disorders [6, 10]. In addition, psychological symptoms have a highly negative impact on the quality of life and are associated with poor treatment adherence, severe physical symptoms, long-term hospitalization, and a reduced survival rate [11]. Therefore, psychological symptoms, such as depression or anxiety, are particularly challenging problems for patients with end-stage HF [12, 13].

Psychiatric care, including pharmacotherapy and psychotherapy, can be of benefit for patients with HF who have psychological symptoms. However, there is inadequate evidence for the efficacy of pharmacotherapy in patients with HF [6, 14], and psychiatric pharmacotherapy, such as antidepressants, increases the risk of all-cause death among HF patients [15]. Nevertheless, psychotherapy has received attention among patients with HF in recent years, and cognitive behavioral therapy in particular has been shown to improve psychological symptoms [16, 17]. Relaxation, meditation, and mindfulness-based psychoeducation can also alleviate these symptoms [18, 19]. However, there is limited evidence and guidance on the efficacy of such psychiatric care among patients with terminal HF [20, 21].

In patients with end-stage cancer, many of whom experience psychological symptoms similar to patients with end-stage HF, many studies have demonstrated the effectiveness of pharmacotherapy and psychotherapy [22,23,24]. Workshops or guidelines for oncologists can also enhance their practical skills in providing end-of-life psychiatric care [25, 26]. A comparison between the difficulties in providing psychiatric care for patients with end-stage HF versus those with cancer could provide useful insights into potential barriers to providing psychiatric care for patients with end-stage HF. However, to date, no study has examined the barriers to providing psychiatric care for patients with HF. In addition, we believe that a qualitative study design, examining thee difficulties faced by health care providers in pain management, would be also helpful in investigating the difficulties with psychiatric management and identifying the barriers to providing psychiatric care [27].

The aims of this study were to identify and compare the barriers faced by health care providers of cardiology and oncology hospitals in providing psychiatric care to end-of-life patients.

Methods

Design and participants

This was a national, cross-sectional survey conducted among Japanese health care providers of cardiology and oncology hospitals using self-completed questionnaires. We mailed the questionnaires to the departments of cardiovascular internal medicine of 427 implantable cardioverter defibrillators (ICD) specialized hospitals and to the departments of respiratory medicine of 347 designated cancer hospitals; we asked them to deliver the questionnaires directly to the chief physicians and the chief nurses in each department in March 2018. ICD specialized hospitals are equipped to perform implantation of ICDs and are the center of cardiovascular medicine in Japan. Additionally, designated cancer hospitals, recommended by the prefectural governments, can provide high-quality cancer treatment, as guaranteed by the Ministry of Health, Labour and Welfare in Japan. These medical facilities provide palliative care by a team of medical professional, provide specialized cancer treatments, establish local cooperation systems for cancer treatments, and provide consultation, support, and information for cancer patients.

Demographic and clinical characteristics

We collected demographic and clinical information from the self-completed questionnaires. First, we included the following data: sex, age, and medical license of the staff of each health care provider. Second, we included the following data: area (Hokkaido/Tohoku, Kanto/Koshinetsu, Chubu/Hokuriku, Kinki, Chugoku/Shikoku, and Kyushu/Okinawa area), hospital type (national medical center, academic medical center, general hospital except academic medical center, specialized hospital), the number of hospital beds, and the presence of a palliative care unit, palliative care team, liaison psychiatry team, palliative care physicians, psychiatrists, and psychologists at hospitals.

Outcome measures

Difficulty in providing palliative care

The Palliative Care Difficulties Scale—a 15-item self-reported scale—was developed in Japan [28]. The responses are scored in the format of a 4-point Likert-type scale ranging from 0 to 3 (overall score range: 0–42). The scale contains of the following five factors, each having three items: (1) alleviating symptoms, (2) expert support, (3) multidisciplinary communication, (4) communication with patient/family, and (5) community coordination. The reliability and validity of this measure were sufficiently supported in an earlier study [29].

Difficulty in providing end-of-life psychiatric care

We developed the following original question (Sup.1) for assessing the difficulty in providing end-of-life psychiatric care: “Do you face challenges in providing psychiatric care for patients at their end of life?” The possible answers were “yes” or “no.”

Barriers to providing end-of-life psychiatric care

To identify the barriers to providing end-of-life psychological care, we asked the following original question (Sup.1) to participants who answered “yes” to the above question: “What challenges do you face in providing psychological care to patients at their end of life?” Participants could respond freely to this open-ended question.

Qualitative analyses

Content analysis was used to analyze the responses to the open ended question answered freely. Content analysis is an objective and systematic procedure used to draw conclusions by creating categories of data from verbatim or unstructured data [30]. We conducted a quantitative content analysis according to previous studies in palliative care settings [28, 31]. Our content analysis procedure was conducted as follows: (1) all text data were divided into thematic units, which are units of words with one logical meaning; (2) two researchers, a clinical psychologist (KI), and a cardiovascular nurse (SM) extracted all statements from the free descriptions related to the study topic, such as the barriers to providing end-of-life psychiatric care; (3) a clinical psychologist (KI), a cardiovascular nurse (SM), and two psychiatrists in the palliative care team (EM and TT) carefully conceptualized similarities and differences in the content, and defined all categories; and (4) two coders, a student of psychology, and a psychiatric clinical nurse independently determined how each thematic unit that was identified corresponded with any category. The concordance rate and kappa coefficient of the determinations of the categories were used as reliability indicators. The kappa coefficient was calculated using 20% of the data and random sampling was conducted based on the data from a standard set derived from a previous study, with more than 10% or 50 units of data [32, 33].

Statistical analyses

First, we summarized the characteristics of the participants and hospitals using standard descriptive statistics. Second, the mean difference in difficulties in providing palliative care was compared between oncological and cardiovascular hospitals using a t test, and the frequency of difficulties in providing end-of-life psychiatric care was compared between oncological and cardiovascular hospitals using χ2 test. Third, the frequency of the thematic units that were categorized in the above content analysis was compared between health care providers in oncological and cardiovascular hospitals using χ2 test. The significance level was set at 5%. All data were analyzed using IBM SPSS Statistics for Windows, version 24 (IBM Corp., NY, USA).

Results

Demographic and clinical characteristics

From the 347 oncology and 427 cardiology hospitals, 130 oncological physicians (37.5%), 94 oncological nurses (27.1%), 120 cardiovascular physicians (28.1%), and 93 cardiovascular nurses (21.8%) were included in the analysis (Fig. 1). The characteristics of the study participants and hospitals are listed in Table 1. More than 90% of physicians were specialists, such as lung cancer or cardiovascular specialists, and approximately half of the nurses were certified in a specialized field, including cancer nursing or palliative care. The sex ratio (men:women) was 1.4:1. Regarding both oncology and cardiology hospitals, more than 90% were general hospitals, approximately 60% were large-scale facilities (≥ 500 hospital beds), more than 80% had palliative care teams, and approximately 70% had psychiatric or psychological care specialists.

Fig. 1
figure 1

Flow diagram of participants

Table 1 Characteristics of participants (health care providers) and hospitals

Difficulty in providing end-of-life palliative and psychiatric care

We found that the Palliative Care Difficulties Scale scores were significantly higher in health care providers among cardiology hospitals compared to that of oncology hospitals for “alleviating symptoms” and “expert support” (F [423] = 8.63, p = 0.00 and F [414] = 18.96, p = 0.00, respectively), whereas no significant differences were found for any other factor (F [426] = 3.50, p = 0.06 for multidisciplinary communication; F [424] = 2.82, p = 0.09 for communication with patient/family; F [423] = 1.11, p = 0.29 for community coordination) (Fig. 2).

Fig. 2
figure 2

Difficulty in providing palliative care (scores)

The frequency of difficulties in providing end-of-life psychiatric care according to the χ2 test and exact probability test is shown in Fig. 3. A total of 135 (62.2%) oncological and 125 (59.8%) cardiovascular health care providers had difficulties in providing end-of-life psychiatric care. There was no significant difference in the frequency of difficulties faced by healthcare providers of oncology and cardiology hospitals (χ2 [1] = 0.26, p = 0.62).

Fig. 3
figure 3

Difficulty in providing end-of-life psychiatric care (%)

Barrier to providing end-of-life psychiatric care using qualitative methods

We extracted 52 attributes from the content analysis, 40 of which were classified by the semantic content into “patients’ personal problems,” “family members’ problems,” “professionals’ personal problems,” “communication problems between professionals and patients,” “problems specific to end-of-life care,” “problems specific to psychiatric care,” “problems of institution or system,” and “problems specific to non-cancer patients” (Table 2). The Kappa coefficient derived by the two independent coders was 0.54 in the random 20% data of this study.

Table 2 Barriers to providing end-of-life psychiatric care

The frequency of barriers to providing psychiatric end-of-life care is shown in Table 3. We found that the “problems specific to non-cancer patients” occurred more frequently in health care providers of cardiology than that of oncology hospitals (χ2 [1] = 22.475, p = 0.00). There was no significant difference between the frequencies of any other barrier between health care providers of oncology and cardiology hospitals.

Table 3 Differences in barriers to providing end-of-life psychiatric care between health care providers of oncology and cardiology hospitals

Discussion

This is the first study that investigated the barriers to providing psychiatric care for end-stage HF patients compared to end-stage cancer patients. Although we found no significant difference in the frequency of those who perceive barriers to providing end-of-life psychiatric care between the cardiology and oncology settings, there can be a difference in the context in which they perceive barriers. A particularly important result was that the cardiovascular health care providers faced problems with psychiatric care, which were specific to non-cancer patients, such as obtaining professional support, useful guidelines, or training opportunities. This study was useful in exploring solutions for providing sufficient psychiatric care for end-stage HF patients, by eliminating barriers using a bottom-up qualitative approach.

Our results indicated that there were three challenges faced by health care providers in providing psychiatric care to end-of-life patients. First, knowledge of mental health issues specific to the end-of-life is necessary for health care providers to provide psychiatric care. Cardiovascular health care providers found it particularly difficult to improve their knowledge and skills for performing psychiatric assessments and for treating psychological and cardiac symptoms. In particular, depression, in addition to fatigue or pain, is one of the most common symptoms and imposes a heavy burden on patients with advanced HF [12, 13, 34]. Some clinical practice guidelines on HF emphasize the need for psychiatric care for HF patients with depression as part of symptom management in Western countries [5, 35]. However, even these guidelines have insufficient information about a specific psychiatric assessment and treatment for patients with HF. Participants in this study also described that they had little access to information needed to improve their knowledge and skills in psychiatric care. For cancer patients, lack of knowledge and training among health care providers is a barrier to providing psychiatric care [36], and therefore some Japanese academic societies have held seminars or workshops to promote psychiatric care knowledge for oncologists or any other health care providers in the last few decades. Taken together, we recommend an expansion of the existing training and education system and provision of detailed guidelines as a way to provide access to methods of psychiatric assessment and treatment for psychological symptoms in patients with advanced HF. Furthermore, physical symptom management was also identified as a difficulty for cardiovascular health care providers compared with oncological health care providers in this study. Interventions directed at alleviating physical symptoms related to HF can lead to a reduction in psychological symptoms in palliative care [37]. In the future, we recommend the development of a training system for end-of-life care professionals aimed at providing training for both physical and psychiatric care.

Second, cooperation among health care providers with different specialties is important in providing psychiatric care for end-stage patients. Many health care providers felt that it was difficult to coordinate professional-patient relationships in both cardiovascular and oncological settings. Interventions to enhance communication between professionals and patients can improve the latter’s psychological well-being [38]. Professional-patient relationship and communication are also important for the quality and outcome of medical treatment [39, 40]. Particularly in palliative settings, a lack of communication between professionals and patients can lead to the inhibition of critical decisions such as ICD deactivations [41, 42]. Practically, general education and specialized education can improve communication skills among health care providers and facilitate professional-patient communication [43, 44]. Advanced care planning can also encourage effective communication between professionals and patients with HF [45, 46]. Therefore, we conclude that a useful tool or training system for improving communication skills as well as psychiatric care skills among health care providers could enhance end-of-life care in cardiovascular settings.

Third, health care providers’ own difficulties and distresses can be resolved to implement psychiatric care smoothly for end-stage patients. A professional’s personal psychological or physical distress could be a barrier to providing psychiatric care. Professional participants in this study described that many cardiovascular and oncological hospitals do not have sufficient staff and are consequently overwhelmed by the workload, leading to unsatisfactory psychiatric care for palliative patients. Health care providers also feel unable to provide sufficient spiritual psychiatric care for end-of-life patients [47]. Reducing the workload and ensuring adequate time management for health care providers remain critical goals in modern Japanese medical settings.

Limitations

Our study has three major limitations. First, recall bias may have occurred because of the self-reported nature of the questionnaires. However, we conducted a content analysis by two researchers independently and ensured objectivity. Second, although the study conducted on a nation-wide level in Japan, the data may not be generalizable to other populations of the world. Therefore, future studies investigating the same research questions in other countries will be essential to validate our findings and to add to the evidence database. Third, as this study was conducted before the COVID-19 pandemic, our findings may not be consistent with the current situation in the Japanese medical field. Although it is noteworthy that the medical field is constantly overwhelmed with achieving a level of infection control, and the perception of health care providers regarding the significance of providing psychiatric care at the end of life is also changing.

Conclusion

Our results demonstrated that (1) both cardiovascular and oncological health care providers perceive the barriers to providing end-of-life psychiatric care; (2) both of them faced challenges in terms of patients’ personal problems, family members’ problems, professionals’ personal problems, communication problems between professionals and patients, problems specific to end-of-life care, problems specific to psychiatric care, problems of institution or system, and problems specific to non-cancer patients; and (3) cardiovascular providers particularly faced challenges specific to non-cancer patients, compared to oncology providers.

These results suggest that health care providers in cardiovascular hospitals, in contrast to those in oncological hospitals, experience problems in obtaining useful guidelines or training opportunities. We recommend the staffing to provide adequate psychiatric care for end-stage HF patients, and the provision of continuous educational opportunities for health care providers involved with psychiatric and palliative care for patients with HF. However, our study also indicates that both oncological and cardiovascular health care providers face challenges in providing end-of-life psychiatric care, which stem from patients’ or health care providers’ personal problems, among others. Therefore, we should also develop strategies to overcome not only the understaffing situation in medical services but also a lack of professionals’ psychiatric care skills.

Data Availability

The datasets generated and/or analyzed during the current study are not publicly available as this permission was not obtained in the informed consent form, however, data are available from the corresponding author on reasonable request.

References

  1. The World Health Organization (WHO). The top 10 causes of death. ; 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 21 October 2022.

  2. Dagenais GR, Leong DP, Rangarajan S, Lanas F, Lopez-Jaramillo P, Gupta R, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2020;395(10226):785–94. https://doi.org/10.1016/S0140-6736(19)32007-0].

    Article  PubMed  Google Scholar 

  3. Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–86. https://doi.org/10.1016/j.jacc.2017.08.074.

    Article  PubMed  Google Scholar 

  4. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–76. https://doi.org/10.1016/j.ijcard.2013.12.028.

    Article  PubMed  Google Scholar 

  5. Sobanski PZ, Alt-Epping B, Currow DC, Goodlin SJ, Grodzicki T, Hogg K, et al. Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement. Cardiovasc Res. 2020;116(1):12–27. https://doi.org/10.1093/cvr/cvz200.

    Article  CAS  PubMed  Google Scholar 

  6. Celano CM, Villegas AC, Albanese AM, Gaggin HK, Huffman JC. Depression and anxiety in heart failure: a review. Harv Rev Psychiatry. 2018;26(4):175–84. https://doi.org/10.1097/HRP.0000000000000162.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kuhlmann SL, Arolt V, Haverkamp W, Martus P, Ströhle A, Waltenberger J, et al. Prevalence, 12-month prognosis, and clinical management need of depression in coronary heart disease patients: a prospective cohort study. Psychother Psychosom. 2019;88(5):300–11. https://doi.org/10.1159/000501502.

    Article  PubMed  Google Scholar 

  8. Rasputina L, Rasputin V, Ovcharuk M, Serhiichuk O, Broniuk A. Prevalence of depression and its grading in patients with coronary heart disease. Georgian Med News. 2016;259(259):48–53.

    Google Scholar 

  9. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527–37. https://doi.org/10.1016/j.jacc.2006.06.055.

    Article  PubMed  Google Scholar 

  10. Easton K, Coventry P, Lovell K, Carter LA, Deaton C. Prevalence and measurement of anxiety in samples of patients with heart failure: meta-analysis. J Cardiovasc Nurs. 2016;31(4):367–79. https://doi.org/10.1097/JCN.0000000000000265.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jani BD, Mair FS, Roger VL, Weston SA, Jiang R, Chamberlain AM. Comorbid depression and heart failure: a community cohort study. PLoS ONE. 2016;11(6):e0158570. https://doi.org/10.1371/journal.pone.0158570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Diamant MJ, Keshmiri H, Toma M. End-of-life care in patients with advanced heart failure. Curr Opin Cardiol. 2020;35(2):156–61. https://doi.org/10.1097/HCO.0000000000000712.

    Article  PubMed  Google Scholar 

  13. Lowey SE. Palliative care in the management of patients with advanced heart failure. Adv Exp Med Biol. 2018;1067:295–311. https://doi.org/10.1007/5584_2017_115.

    Article  PubMed  Google Scholar 

  14. Rajeswaran T, Plymen CM, Doherty AM. The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression - A systematic review. Int J Psychiatry Clin Pract. 2018;22(3):164–9. https://doi.org/10.1080/13651501.2017.1401085.

    Article  CAS  PubMed  Google Scholar 

  15. He W, Zhou Y, Ma J, Wei B, Fu Y. Effect of antidepressants on death in patients with heart failure: a systematic review and meta-analysis. Heart fail rev. 2020;25:919–26. https://doi.org/10.1007/S10741-019-09850-W.

    Article  CAS  PubMed  Google Scholar 

  16. Jeyanantham K, Kotecha D, Thanki D, Dekker R, Lane DA. Effects of cognitive behavioural therapy for depression in heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2017;22:731–41. https://doi.org/10.1007/s10741-017-9640-5.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Peng Y, Fang J, Huang W, Qin S. Efficacy of cognitive behavioral therapy for heart failure. Int Heart J. 2019;60:665–70. https://doi.org/10.1536/ihj.18-408.

    Article  PubMed  Google Scholar 

  18. Kwekkeboom KL, Bratzke LC. A systematic review of relaxation, meditation, and guided imagery strategies for symptom management in heart failure. J Cardiovasc Nurs. 2016;31(5):457–68. https://doi.org/10.1097/JCN.0000000000000274.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sullivan MJ, Wood L, Terry J, Brantley J, Charles A, McGee V, Johnson D, Krucoff MW, Rosenberg B, Bosworth HB, Adams K, Cuffe MS. The support, Education, and Research in Chronic Heart failure study (search): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am heart J. 2009;157:84–90. https://doi.org/10.1016/J.AHJ.2008.08.033.

    Article  PubMed  Google Scholar 

  20. Murray SA, Kendall M, Grant E, Boyd K, Barclay S, Sheikh A. Patterns of social, psychological, and spiritual decline toward the end of life in lung cancer and heart failure. J Pain Symptom Manage. 2007;34(4):393–402. https://doi.org/10.1016/J.JPAINSYMMAN.2006.12.009.

    Article  PubMed  Google Scholar 

  21. MacMahon KM, Lip GY. Psychological factors in heart failure: a review of the literature. Arch Intern Med. 2002;162(5):509–16. https://doi.org/10.1001/ARCHINTE.162.5.509.

    Article  PubMed  Google Scholar 

  22. Wang CW, Chow AY, Chan CL. The effects of life review interventions on spiritual well-being, psychological distress, and quality of life in patients with terminal or advanced cancer: a systematic review and meta-analysis of randomized controlled trials. Palliat Med. 2017;31(10):883–94. https://doi.org/10.1177/0269216317705101.

    Article  PubMed  Google Scholar 

  23. Okuyama T, Akechi T, Mackenzie L, Furukawa TA. Psychotherapy for depression among advanced, incurable cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2017;56:16–27. https://doi.org/10.1016/j.ctrv.2017.03.012.

    Article  PubMed  Google Scholar 

  24. Simon ST, Pralong A, Radbruch L, Bausewein C, Voltz R. The Palliative Care of patients with Incurable Cancer. Dtsch Arztebl int. 2020;116(7):108–15. https://doi.org/10.3238/ARZTEBL.2020.0108.

    Article  PubMed  Google Scholar 

  25. Inoue A, Yamaguchi T, Tanaka K, Sakashita A, Aoe K, Seki N, et al. Benefits of a nationwide palliative care education program on lung cancer physicians. Intern Med. 2019;58(10):1399–403. https://doi.org/10.2169/INTERNALMEDICINE.0872-18.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Howell D, Keshavarz H, Esplen MJ et al. Pan-Canadian practice guideline: screening, assessment and management of psychosocial distress, depression and anxiety in adults with cancer; 2015. In: Can. Assoc. Psychosoc Oncol. Available from: http://www.capo.ca/. Accessed 21 October 2022.

  27. Chen J, Walsh S, Delaney C, Cong X. Pain management in patients with heart failure: a survey of nurses’ perception. Pain Manag Nurs. 2020;21(4):365–70. https://doi.org/10.1016/j.pmn.2019.09.004.

    Article  PubMed  Google Scholar 

  28. Hirai K, Miyashita M, Morita T, Sanjo M, Uchitomi Y. Good death in japanese cancer care: a qualitative study. J Pain Symptom Manage. 2006;31(2):140–7. https://doi.org/10.1016/j.jpainsymman.2005.06.012.

    Article  PubMed  Google Scholar 

  29. Nakazawa Y, Miyashita M, Morita T, Umeda M, Oyagi Y, Ogasawara T. The palliative care self-reported practices scale and the palliative care difficulties scale: reliability and validity of two scales evaluating self-reported practices and difficulties experienced in palliative care by health professionals. J Palliat Med. 2010;13(4):427–37. https://doi.org/10.1089/jpm.2009.0289.

    Article  PubMed  Google Scholar 

  30. Krippendorff KH. Content analysis: an introduction to its methodology. SAGE Publications, Inc; 2018.

  31. Miyashita M, Hirai K, Morita T, Sanjo M, Uchitomi Y. Barriers to referral to inpatient palliative care units in Japan: a qualitative survey with content analysis. Supportive Care Cancer. 2008;16(3):217–22. https://doi.org/10.1007/s00520-007-0215-1.

    Article  Google Scholar 

  32. Lombard M, Snyder-Duch J, Bracken CC. Practical resources for assessing and reporting intercoder reliability in content analysis research projects; 2005. Available from: https://www.researchgate.net/publication/242785900_Practical_Resources_for_Assessing_and_Reporting_Intercoder_Reliability_in_Content_Analysis_Research_Projects. Accessed 21 October 2022.

  33. Lombard M, Snyder-Duch J, Bracken CC. A call for standardization in content analysis reliability. Hum Commun Res. 2004;30:434–7.

    Article  Google Scholar 

  34. Alpert CM, Smith MA, Hummel SL, Hummel EK. Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev. 2017;22(1):25–39. https://doi.org/10.1007/S10741-016-9581-4.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129(12):1350–69. https://doi.org/10.1161/CIR.0000000000000019.

    Article  PubMed  Google Scholar 

  36. Granek L, Nakash O, Ariad S, Shapira S, Ben-David M, et al. Strategies and barriers in addressing Mental Health and Suicidality in patients with Cancer. Oncol Nurs Forum. 2019;46(5):561–71. https://doi.org/10.1188/19.ONF.561-571.

    Article  PubMed  Google Scholar 

  37. Doorenbos AZ, Levy WC, Curtis JR, Dougherty CM. An intervention to enhance goals-of-care communication between heart failure patients and heart failure providers. J Pain Symptom Manag. 2016;52(3):353–60. https://doi.org/10.1016/j.jpainsymman.2016.03.018.

    Article  Google Scholar 

  38. Prip A, Møller KA, Nielsen DL, Jarden M, Olsen MH, Danielsen AK. The patient-healthcare professional relationship and communication in the oncology outpatient setting: a systematic review. Cancer Nurs. 2018;41(5):E11–22. https://doi.org/10.1097/NCC.0000000000000533.

    Article  PubMed  Google Scholar 

  39. Farmer SA, Magasi S, Block P, Whelen MJ, Hansen LO, Bonow RO et al. Patient, caregiver, and physician work in heart failure disease management: A qualitative study of issues that undermine wellness. Mayo Clin Proc. 2016;91(8):1056-65. doi: https://doi.org/10.1016/J.MAYOCP.2016.05.016.

  40. Parajuli J, Tark A, Jao YL, Hupcey J. Barriers to palliative and hospice care utilization in older adults with cancer: a systematic review. J Geriatr Oncol. 2020;11(1):8–16. https://doi.org/10.1016/j.jgo.2019.09.017.

    Article  PubMed  Google Scholar 

  41. Goldstein NE, Mather H, McKendrick K, Gelfman LP, Hutchinson MD, Lampert R, et al. Improving communication in heart failure patient care. J Am Coll Cardiol. 2019;74(13):1682–92. https://doi.org/10.1016/J.JACC.2019.07.058.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Tu J, Kang G, Zhong J, Cheng Y. Outpatient communication patterns in a cancer hospital in China: a qualitative study of doctor-patient encounters. Health Expect. 2019;22(3):594–603. https://doi.org/10.1111/HEX.12890.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Gelfman LP, Kavalieratos D, Teuteberg WG, Lala A, Goldstein NE. Primary palliative care for heart failure: what is it? How do we implement it? Heart Fail Rev. 2017;22(5):611–20. https://doi.org/10.1007/s10741-017-9604-9.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Schichtel M, Wee B, Perera R, Onakpoya I. The effect of advance care planning on heart failure: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(3):874–84. https://doi.org/10.1007/S11606-019-05482-W.

    Article  PubMed  Google Scholar 

  45. Hauser J. Communication in heart failure and palliative care. Heart Fail Rev. 2017;22(5):535–42. https://doi.org/10.1007/s10741-017-9643-2.

    Article  PubMed  Google Scholar 

  46. Rogers JG, Patel CB, Mentz RJ, Granger BB, Steinhauser KE, Fiuzat M et al. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.J Am Coll Cardiol. 2017 Jul18;70(3):331–341. doi: https://doi.org/10.1016/j.jacc.2017.05.030.

  47. Harasym P, Brisbin S, Afzaal M, Sinnarajah A, Venturato L, Quail P, Kaasalainen S, Straus SE, Sussman T, Virk N, Holroyd-Leduc J. Barriers and facilitators to optimal supportive end-of-life palliative care in long-term care facilities: a qualitative descriptive study of community-based and specialist palliative care physicians’ experiences, perceptions and perspectives. BMJ Open. 2020;10:e037466. https://doi.org/10.1136/bmjopen-2020-037466.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We are grateful to Satoko Ogi, Tomoko Sugano, Wakana Takeshita, and Yoriko Mizukane for assisting in making a list of delivery addresses and affixing a shipping label to mailing envelopes. We would also like to thank all health care providers who participated in this study.

Funding

This study was supported by a grant from JSPS KAKENHI (Grant Number: JP16J00179) and scholarship donations from Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation, MSD K.K., Otsuka Pharmaceutical, Pfizer Inc., and Takeda Pharmaceutical Company Ltd. However, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

KI, SM, and EM conceptualized this study. KI curated the data. KI, SM, and HI conducted the formal analyses. KI and EM acquired the funding. KI conducted the study, designed the study methodology, oversaw the project administration, obtained the study’s resources, and operated the software. HC supervised the qualitative analyses. HT and TT supervised the study. KI validated the study results, created the visualizations, and wrote the original draft. SM, HC, HI, YF, HM, HT, TT, and EM reviewed and edited the draft. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Kanako Ichikura.

Ethics declarations

Ethics approval and consent to participate

Written informed consent to participate was obtained from all the participants. They were informed about the aims of the present study and that they had the freedom to quit the survey at any time of their participation. Then, they marked a form checkbox field as a statement of consent when they returned the questionnaires. Our study was approved without undergoing assessment by the institutional review board at the Tokyo Medical and Dental University in Japan, as it was an anonymized, non-invasive, self-completed questionnaire study for health care providers. However, all procedures were in accordance with the ethical standards of the responsible committees on human experimentation (institutional and national) and with the tenets of the Helsinki Declaration of 1975, as revised in 2000.

Consent for publication

Not applicable.

Competing Interest

KI is an advisor to the development of personal health care services by Clinical Study Support, Inc. YF received research grants from the Murata Science Foundation. HT is an advisor of a clinical trial by Taisho Pharmaceutical Holdings and a committee member of the Medical Research Ethics Committee of the Nikon Corporation and the Japan Aerospace Exploration Agency. SM, HC, HI, HM, TT, and EM have no competing interests to report.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Sup. 1 The questionnaire English translated version

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ichikura, K., Matsuoka, S., Chiba, H. et al. Health care providers’ perspectives on providing end-of-life psychiatric care in cardiology and oncology hospitals: a cross-sectional questionnaire survey. BMC Palliat Care 22, 23 (2023). https://doi.org/10.1186/s12904-023-01138-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12904-023-01138-z

Keywords